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Antibodies in the sera of patients with lacaziosis recognized an 193-kDa antigen and other Lacazia loboi
antigens. Paracoccidioides brasiliensis gp43 antigen was detected by all evaluated sera, but they failed to detect
a protein with the same molecular mass in L. loboi extracts. This study is the first to examine the humoral
response to L. loboi antigens by using multiple host sera.
Lacazia loboi is an uncultivated fungal pathogen predomi-
nantly restricted to Latin America. Lacaziosis has been re-
corded among humans dwelling in this geographical area, tour-
ists visiting areas of endemicity (4, 10), and workers handling
infected dolphins (19, 24). Lacaziosis has also been diagnosed
in dolphins inhabiting the coastal areas of the United States (9,
12, 19), Brazil (16), and France (25). Using molecular meth-
ods, the phylogenetic features of L. loboi were only recently
deciphered (13, 18, 31). These studies placed L. loboi as a sister
group to Paracoccidioides brasiliensis and, in turn, linked to the
other dimorphic members of the Onygenales in the family
Ajellomycetaceae.
The clinical features of Lacazia loboi and P. brasiliensis in-
fections are different, but both fungi develop yeast cells, which
are difficult to differentiate microscopically, in the host’s in-
fected tissues (7). This resemblance was used by some inves-
tigators to classify this pathogen in the genus Paracoccidioides
(1, 6, 8). Thus, due to L. loboi’s inability to grow in culture,
immunological studies have traditionally been carried out with
antigens extracted from mycelial cultures of P. brasiliensis (15,
17, 21, 23–27, 30). The objective of our study was to charac-
terize the immunogenic proteins extracted from L. loboi yeast-
like cells in Western blotting analyses, using sera from humans
and dolphins with lacaziosis and sera from experimentally in-
fected mice.
Sera from four human patients with lacaziosis from Acre
State, Brazil, and from one Brazilian patient with proven para-
coccidioidomycosis and four sera from experimentally L. loboi-
infected mice were collected and stored at80°C until use (2).
Sera from three bottlenose dolphins (Tursiops truncatus) in-
fected with L. loboi were evaluated: one wild dolphin infected
with L. loboi was captured in the Indian River Lagoon, FL, one
was a stranded Indian River Lagoon bottlenose dolphin, and
one was a captive bottlenose dolphin from SeaWorld in San
Diego, CA. In addition, two sera from apparently healthy hu-
mans, two sera from healthy dolphins, and two sera from
healthy laboratory mice were used as negative controls.
Lacazia loboi yeast-like cell extracts were obtained from the
footpads of a previously infected BALB/c mouse 6 months
after inoculation, as described by Belone et al. (2). Briefly, L.
loboi yeast-like cells were then centrifuged for 10 min at 3,000
rpm, and the supernatant was discarded. Cells were washed
twice with saline, and the pellet was suspended in 1 ml of
saline. Fungal cells were macerated to a powder with liquid
nitrogen inside a mortar and used in the experiments. The
gp43 protein of P. brasiliensis was extracted and purified per
the method of Taborda et al. (28). Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and Western blot analyses
were done per the methods of Laemmli (14) and Towbin et al.
(29).
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The diagnosis of lacaziosis in the investigated humans and
dolphins was confirmed by clinical and histopathological meth-
ods (Fig. 1). The stained gels of L. loboi protein extracts
showed at least 10 bands, ranging from 193 kDa to 9.0 kDa
(Fig. 2). The L. loboi protein extract lacked a visible protein
band at 43 kDa. The purified gp43 protein of P. brasiliensis
showed a strong band at the expected molecular mass and did
not contain other proteins (Fig. 2). Normal mouse skin tissue
samples processed as described above did not show visible
bands (data not shown).
The immunoglobulin G (IgG) antibodies in the sera of all
tested hosts with lacaziosis detected the gp43 protein of P.
brasiliensis fairly well (Fig. 3). The tested dolphin, human, and
experimentally infected mouse sera detected a major, immu-
nodominant, 193-kDa antigen in the L. loboi protein extract
(Fig. 3) and also reacted weakly with other immunogenic an-
tigens (Fig. 3). The experimentally infected mouse antibodies
mildly detected five other immunogens, including an 48-kDa
protein not detected by the other sera (Fig. 3, panel 2, lane b,
arrowhead). The IgG antibodies of the dolphins detected only
two high-molecular-mass antigens in the L. loboi protein ex-
tract, including the immunodominant, 193-kDa antigen (Fig.
3, panel 3, lane b). The antibodies in the serum from a patient
with paracoccidioidomycosis weakly detected at least 13 other
antigenic components in the L. loboi protein extract, ranging
from 193 kDa to 9.0 kDa. Some of these antigens were not
detected by the antibodies in the sera from humans and dol-
phins with lacaziosis or the antibodies in the sera from exper-
imentally infected mice (Fig. 3, panel 4, lane b). Only the
antibodies in the serum from the patient with paracoccidioid-
omycosis weakly detected a molecular antigen of 43 kDa in the
L. loboi protein extract (Fig. 3, panel 4, lane b). The healthy
FIG. 1. Human parakeloidal (A) and dolphin verrucous (B) lesions
from two of the hosts with lacaziosis used in this study. The histopa-
thology of these lesions is shown in panels C (human) (silver stain;
magnification, 100) and D (dolphin) (silver stain; magnification,
40).
FIG. 2. Coomassie blue-stained sodium dodecyl sulfate-polyacryl-
amide gel showing purified Paracoccidioides brasiliensis gp43 (lane 1)
and the profile of an Lacazia loboi protein extract (lane 2). The figure
shows the 193-kDa immunodominant antigen (arrow) as well as
other proteins in the L. loboi protein extract. The asterisks indicate
common proteins detected by the sera tested in this study. Lane M,
molecular mass marker.
FIG. 3. Western blot analyses of transferred proteins on nylon
membranes. The antibodies in the serum from a human with lacaziosis
weakly detected Paracoccidioides brasiliensis gp43 (lane 1a). This se-
rum strongly detected an193-kDa immunodominant antigen (arrow)
as well as six other weak bands (asterisks) (lane 1b). The IgG in the
serum from the experimentally infected mouse weakly detected P.
brasiliensis gp43 (lane 2a). The mouse antibodies strongly detected the
193-kDa immunodominant antigen (arrow) as well as seven other
proteins (asterisks) and an 48-kDa protein not detected by the other
sera (lane 2b, arrowhead). The antibodies in the dolphin with lacaziosis
slightly detected P. brasiliensis gp43 (lane 3a). The antibodies strongly
recognized the 193-kDa immunodominant antigen (arrow) and only
one of the minor antigens previously detected in the L. loboi extract
(lane 3b). The antibodies in the serum from the patient with paracoc-
cidioidomycosis strongly detected gp43 (lane 4a). The antibodies of
this patient also detected the immunodominant 193-kDa antigen
(arrow) in the L. loboi extract as well as other antigens (asterisks),
including a 43-kDa antigen (arrowhead) (lane 4b). The molecular mass
marker (lanes M) appears in each of the panels.
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control human, dolphin, and mouse sera did not react with the
antigens used in this study (data not shown). One of the two
control dolphin sera possessed antibodies against the 43-kDa
purified protein of P. brasiliensis and the major antigens of L.
loboi normally detected by the dolphins with lacaziosis. Puta-
tive residual normal mouse skin cells were not detected by the
tested sera (data not shown).
With the exception of three previous studies (1, 23, 30), in
the past 75 years L. loboi immunological research has been
carried out using antigens of P. brasiliensis (6, 8, 15, 17, 21, 24,
26, 27, 32). Our study showed that patients with lacaziosis
possessed antibodies not only against the gp43 antigen of P.
brasiliensis but mainly against an 193-kDa immunodominant
L. loboi antigen. The possibility that the 193-kDa antigen
comprises several compressed L. loboi immunogens is cur-
rently under investigation in our laboratory. The IgGs in the
sera from patients with lacaziosis failed to detect the gp43-like
antigen in the protein extract of L. loboi. However, the serum
from the patient with paracoccidioidomycosis did detect an
antigen with a similar molecular mass. The cross-reactive an-
tigens reported in this study, including purified gp43 and those
reported by other investigators (1, 6, 15, 21, 24, 26, 30), were
not unexpected, since recent molecular studies have shown
that both L. loboi and P. brasiliensis share the same ancestor
(13, 18, 31).
The many reports of lacaziosis in dolphins have puzzled
investigators for decades (3, 5, 9, 12, 19, 22, 25, 32). However,
studies to elucidate its etiology, epidemiology, and immunol-
ogy have been equally challenging (5, 22, 25). Our study
showed that dolphins develop IgG antibodies against similar
prominent antigens to those recognized by humans with laca-
ziosis and by experimentally infected mice. Interestingly, one
of the negative control dolphins detected the gp43 antigen of
P. brasiliensis and the other major antigens of L. loboi identi-
fied by dolphins with lacaziosis. This unexpected result sug-
gests a previous exposure to L. loboi without disease, as it is
frequent among the other dimorphic members of the Onyge-
nales (15, 17, 20). Thus, Western blotting analyses could be a
useful tool for epidemiological studies of L. loboi. Although
some investigators have reported morphological differences
between the yeast-like cells of L. loboi in both species (11), our
study is the first to suggest that dolphins are infected with
similar L. loboi strains to those infecting humans.
In contrast to previous serological reports (1, 23, 30), this
study suggests that during infection, L. loboi presents immu-
nogens to the immune system which are different from that in
P. brasiliensis infection. The molecular characterization of
these antigens, especially the 193-kDa immunodominant an-
tigen, could generate valuable information to better under-
stand the immunology and serology of L. loboi infection and
possibly aid in the development of new therapies for infections
caused by this resilient fungal pathogen.
Lesions from the free-ranging dolphin were collected under Na-
tional Marine Fisheries Service scientific research permit no. 998-1678,
issued to Gregory D. Bossart as part of the Bottlenose Dolphin Health
and Risk Assessment (HERA) Project conducted in the Indian River
Lagoon, FL, and the estuarine waters of Charleston, SC. Samples from
the stranded dolphin were collected under a National Marine Fisheries
Service letter of agreement, and this collection was supported in part
under award NA06NMF4390138 from the National Oceanic and At-
mospheric Administration, U.S. Department of Commerce. This re-
search was supported in part by the Biomedical Laboratory Diagnosis
Program, Michigan State University, MI.
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